Correlation Engine 2.0
Clear Search sequence regions


  • angiogenesis (1)
  • cell cycle (1)
  • cellular (1)
  • humans (1)
  • il 17 (1)
  • PDE 4 (1)
  • phase (2)
  • protein human (1)
  • psoriasis (9)
  • research (1)
  • Skp2 (8)
  • skp2 protein (1)
  • TNF α (1)
  • ubiquitin (4)
  • Sizes of these terms reflect their relevance to your search.

    Psoriasis is a chronic immune-mediated disorder affecting over 2-3% of the population worldwide, significantly impacting quality of life. Despite the availability of various therapeutic interventions, concerns persist regarding lesion recurrence and potential alterations in immune surveillance promoting cancer progression. Recent advancements in understanding cellular and molecular pathways have unveiled key factors in psoriasis etiology, including IL-17, 22, 23, TNF-α, PDE-4, JAK-STAT inhibitors, and AhR agonists. This work explores the potential of S-phase kinase-associated protein 2 (Skp2) as a therapeutic target in psoriasis. This review covers the current understanding of psoriasis pathophysiology, including immune dysregulation, and the role of keratinocytes and ubiquitin. It also delves into Skp2 role in cell cycle regulation, and its correlation with angiogenesis and ubiquitin in psoriasis. The evolving therapeutic approaches targeting Skp2, including small molecule inhibitors, are also discussed. Targeting Skp2 holds promise for developing novel therapeutic approaches for psoriasis. By modulating Skp2 activity or expression, it may be possible to intervene in inflammatory and proliferative processes underlying the disease. Further research into Skp2 inhibitors and their efficacy in preclinical and clinical settings is warranted to harness the full potential of Skp2 as a therapeutic target in psoriasis management.

    Citation

    Yashika Tomar, Moushumi Baidya, Jay Chadokiya, Shvetank Bhatt, Gautam Singhvi. An overview of Skp2: a promising new therapeutic target of psoriasis. Expert opinion on therapeutic targets. 2024 Aug;28(8):689-700

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 39086205

    View Full Text